HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 53 filers reported holding HARPOON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $205,046 | +26221.7% | 288,797 | -72.4% | 0.00% | – |
Q1 2023 | $779 | -13.2% | 1,046,523 | -15.3% | 0.00% | – |
Q4 2022 | $897 | -99.9% | 1,236,289 | +81.5% | 0.00% | – |
Q3 2022 | $661,000 | -40.3% | 681,172 | +17.5% | 0.00% | -100.0% |
Q2 2022 | $1,108,000 | +1144.9% | 579,919 | +3145.9% | 0.00% | – |
Q1 2022 | $89,000 | -88.4% | 17,866 | -82.4% | 0.00% | – |
Q4 2021 | $768,000 | -83.9% | 101,775 | -83.1% | 0.00% | -100.0% |
Q3 2021 | $4,762,000 | +261.0% | 602,752 | +534.1% | 0.00% | +200.0% |
Q2 2021 | $1,319,000 | -42.6% | 95,063 | -13.5% | 0.00% | 0.0% |
Q1 2021 | $2,299,000 | -23.6% | 109,917 | -39.3% | 0.00% | -50.0% |
Q4 2020 | $3,010,000 | -9.2% | 181,207 | -9.2% | 0.00% | -60.0% |
Q2 2020 | $3,315,000 | +249.3% | 199,673 | +143.7% | 0.01% | +150.0% |
Q1 2020 | $949,000 | -20.8% | 81,937 | +1.1% | 0.00% | +100.0% |
Q4 2019 | $1,198,000 | +478.7% | 81,020 | +408.7% | 0.00% | – |
Q2 2019 | $207,000 | -82.7% | 15,928 | -87.4% | 0.00% | -100.0% |
Q1 2019 | $1,199,000 | – | 126,656 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |